Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PACS
PACS logo

PACS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pacs Group Inc (PACS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
41.890
1 Day change
2.97%
52 Week Range
43.080
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Pacs Group Inc (PACS) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment at this time. While the stock has shown positive price movement recently and analysts have raised price targets, the lack of strong technical signals, neutral insider and hedge fund activity, and absence of significant news catalysts suggest a cautious approach. Holding the stock or waiting for clearer signals is recommended.

Technical Analysis

The MACD histogram is negative and contracting (-0.107), indicating a lack of strong upward momentum. RSI is neutral at 57.411, and moving averages are converging, suggesting no clear trend. Key support is at 34.413, and resistance is at 37.355. The stock is currently trading near its resistance level.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • Analysts have raised price targets recently, with Truist increasing the target to $52 and Oppenheimer to $48, reflecting confidence in the company's performance.

  • The stock has shown a 3.83% regular market gain and a 0.57% pre-market gain.

Neutral/Negative Catalysts

  • No recent news or event-driven catalysts to drive significant momentum.

  • Neutral insider and hedge fund trading activity.

  • Technical indicators do not show strong bullish signals.

  • Stock trend analysis indicates a 60% chance of a -2.76% decline in the next day.

Financial Performance

No financial data available for assessment. The company's latest quarter performance is not provided.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish, with recent upgrades in price targets and positive commentary on the company's performance. Truist raised the target to $52, and Oppenheimer raised it to $48, citing an impressive quarter and regained traction with the Street.

Wall Street analysts forecast PACS stock price to rise
5 Analyst Rating
Wall Street analysts forecast PACS stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 40.680
sliders
Low
40
Averages
42.6
High
47
Current: 40.680
sliders
Low
40
Averages
42.6
High
47
Truist
Buy
maintain
$50 -> $52
AI Analysis
2026-05-18
Reason
Truist
Price Target
$50 -> $52
AI Analysis
2026-05-18
maintain
Buy
Reason
Truist raised the firm's price target on Pacs Group to $52 from $50 and keeps a Buy rating on the shares. The firm is updating its model to reflect the company's Q1 results and updated 2026 guidance, the analyst tells investors in a research note.
Oppenheimer
Michael Wiederhorn
Outperform
maintain
$42 -> $48
2026-05-13
Reason
Oppenheimer
Michael Wiederhorn
Price Target
$42 -> $48
2026-05-13
maintain
Outperform
Reason
Oppenheimer analyst Michael Wiederhorn raised the firm's price target on Pacs Group to $48 from $42 and keeps an Outperform rating on the shares after the company reported earnings. Overall, the firm believes the company had a really impressive quarter, as Pacs Group continues to re-gain traction with the Street.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PACS
Unlock Now

People Also Watch